Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial

By sjmartinez • October 13, 2022

Corren J, Larson D, Altman MC, Segnitz RM, Avila PC, Greenberger PA, Baroody F, Moss MH, Nelson H, Burbank AJ, Hernandez ML, Peden D, Saini S, Tilles S, Hussain I, Whitehouse D, Qin T, Villarreal M, Sever M, Wheatley LM, Nepom GT, Sanda S; Immune Tolerance Network ITN057AD CATNIP Study Team. Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial. J Allergy Clin Immunol. 2022 Oct 9:S0091-6749(22)01333-1. doi: 10.1016/j.jaci.2022.08.029. Epub ahead of print. PMID: 36223848.

Tags: Allergy, cytokine, epithelium, Inflammation, late phase, lymphocyte, mast cell, Med Peds, Publications, rhinitis, thymic stromal lymphopoietin, tolerance, tryptase

Meta-analysis of Psychotherapy for Autistic Youth

Rosenau KA, Kim J, Cho AB, Seltzer M, Ugueto AM, Weisz JR, Wood JJ. Meta-analysis of Psychotherapy for Autistic Youth. Child Psychiatry Hum Dev. 2024[...]

A Quality Improvement Initiative to Improve Health Care Transition Planning at Adolescent Well Visits

Arons A, Tsevat RK, Hotez E, Huang H, Nott R, Ahn H, Mehta N, Nguyen L, Nguyen V, Rebollar AG, Duan S, Ma J. A[...]

Measurement matters: A commentary on the state of the science on patient reported outcome measures (PROMs) in autism research

Schiltz HK, Williams ZJ, Zheng S, Kaplan-Kahn EA, Morton HE, Rosenau KA, Nicolaidis C, Sturm A, Lord C; Autism PROMnet. Measurement matters: A commentary on[...]